Visceral leishmaniasis complicating chronic hepatitis B treated with interferon
β Scribed by Giovanna Fattovich; G. Giustina; F. Adami
- Publisher
- Springer-Verlag
- Year
- 1992
- Tongue
- English
- Weight
- 231 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0300-8126
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The aim of the study was to investigate whether an ''inapparent'' coinfection by hepatitis B virus (HBV) in anti-HCV-positive chronic liver disease patients may influence interferon (IFN) response. Fourteen anti-HCV-positive, hepatitis B surface antigen (HBsAg)-negative but serum HBV-DNA-positive pa
To evaluate the possible usefulness of simultaneous administration of levamisole and interferon, we randomly allocated 38 children with chronic hepatitis B to receive either 10 MU/m2 interferon-a-2a, three times a week for 6 mo (group 1, n = 20) or 90 mg/m" of levamisole for 45 days, together with 1
We studied the binding of ""I-labeled human interferon-a to peripheral blood mononuclear cells and the activity of 2',5'-oligoadenylate synthetase in peripheral blood mononuclear cells obtained from 2 l patients with chronic hepatitis B who were treated with human interferon-a or interferon+. Fourte
Chronic hepatitis C (non-A, non-B hepatitis) is a common and often progressive viral liver diseeee. To aegees the efficacy of therapy with the antiviral agent interferon alfa, we randomly assigned 166 patients with chronic hepatitis C to treatment with either 3 million or 1 million units of recombin
## Abstract In order to assess the efficacy of interferonβΞ± on hepatitis C viral RNA in patients with chronic hepatitis C, we analyzed the levels of HCV RNA in sera and liver tissues of 16 patients preβ and posttreatment using a semiquantitative polymerase chain reaction method. Fifteen of 16 patie